X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-06 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale+OE | $91.50 | -25,590 | 99,599 | -20% | -$2,341,485 | |||||
2024-10-01 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $83.83 | -2,000 | 100,189 | -2% | -$167,660 | ||||||
| D | 2024-09-12 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale+OE | $84.50 | -21,246 | 102,189 | -17% | -$1,795,287 | |||||
2024-07-01 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $68.63 | -2,000 | 96,380 | -2% | -$137,260 | ||||||
2024-04-01 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $72.96 | -2,000 | 96,304 | -2% | -$145,920 | ||||||
| M | 2024-02-28 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $72.82 | -10,230 | 92,706 | -10% | -$744,984 | |||||
2023-09-12 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $76.99 | -1,501 | 70,130 | -2% | -$115,562 | ||||||
2023-06-13 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $76.90 | -1,485 | 29,402 | -5% | -$114,197 | ||||||
2023-03-13 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $78.99 | -6,126 | 70,130 | -8% | -$483,893 | ||||||
2023-03-01 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $79.96 | -12,984 | 70,130 | -16% | -$1,038,225 | ||||||
2022-12-30 | GILD | Parsey Merdad | Chief Medical Officer | S - Sale | $85.33 | -553 | 45,556 | -1% | -$47,187 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |